Skip to content

Oxycodone vs. sufentanil in patient controlled intravenous analgesia after abdominal operation: a randomised, double-blinded, multiple-center clinical trial

Comparison of oxycodone and sufentanil in patient controlled intravenous analgesia after abdominal surgery: a randomized, double blinded, multiple-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17013515
Enrollment
Unknown
Registered
2017-11-23
Start date
2017-04-03
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute postoperative pain

Interventions

Oxycodone group:Oxycodone iv. injection
sufentanil:sufentanil iv. injection

Sponsors

The second affiliated hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults patients undergoing selective abdominal surgery were included. Patients aged 18-6 year-old, BMI 18-29.5, ASA I-III

Exclusion criteria

Exclusion criteria: Patients with cardiac, pulmonary, hepatic or renal insufficiency, drug history including opioid analgesics, NSAIDs, sedative and antidepressant more than 1 month, alcohol abuse history, having mental diseases, sever hypertention ( systolic pressure>180mmHg, diastolic pressure>110mmHg), esophageal reflux disease, having sedative, antiemetic or anti-Itch drugs 24 hours before operation, pregnancy or lactation,and those unable to comprehend verbal instruction were removed from this clinical trial.

Design outcomes

Primary

MeasureTime frame
PCIA times in wards;analgesic does consumption;length of first first patient control intravenous analgesia since returning to wards from PACU;FAS scores;

Secondary

MeasureTime frame
extubation time;PACU staying time;length between extubation and discharge from PACU;rescues analgesia rate in PACU;

Countries

China

Contacts

Public ContactSiyuan Li

The second affiliated hospital of Xi'an jiaotong University

foxlsy@163.com+86 18681875961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026